Introduction of Hib vaccine into national immunization programmes: A descriptive analysis of global trends

被引：22

作者：

Rossi, Isabelle A.

Zuber, Patrick L. F.

Dumolard, Laure

Walker, Damian G.

Watt, James

机构：

[1] WHO, FCH, Dept Immunizat Vaccines & Biol IVB, CH-1211 Geneva 27, Switzerland

[2] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA

来源：

VACCINE | 2007年 / 25卷 / 41期

关键词：

Hib vaccine; WHO member states; vaccine introduction;

D O I：

10.1016/j.vaccine.2007.07.058

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Despite the demonstration of effectiveness and public health impact of Hib conjugate vaccines, the majority of infants from poorest countries do not yet have access to this safe and effective preventive intervention. This paper provides a descriptive analysis of the main characteristics of countries that have included Hib vaccine in their national immunization programmes before 2006. It highlights the importance of regularly analyzing the process of decision-making involved in implementation of public health interventions, in order to learn from cumulative experience and expedite the introduction of future interventions. (c) 2007 Elsevier Ltd. All rights reserved.

引用

页码：7075 / 7080

页数：6

共 50 条

[21] The cost of integrating hepatitis B virus vaccine into national immunization programmes: a case study from Addis Ababa
Edmunds, WJ
Dejene, A
Mekonnen, Y
Haile, M
Alemnu, W
Nokes, DJ
HEALTH POLICY AND PLANNING, 2000, 15 (04) : 408 - 416
[22] Haemophilus influenzae serotype b conjugate vaccine failure in twelve countries with established national childhood immunization programmes
Ladhani, S.
Heath, P. T.
Slack, M. P. E.
McIntyre, P. B.
Diez-Domingo, J.
Campos, J.
Dagan, R.
Ramsay, M. E.
CLINICAL MICROBIOLOGY AND INFECTION, 2010, 16 (07) : 948 - 954
[23] Recent Trends in Global Adverse Event Reporting: A Descriptive Analysis of VigiBase
Brand, Judith S.
Gauffin, Oskar
Sartori, Daniele
Skold, Helena
Bergvall, Tomas
Sandberg, Lovisa
Wallberg, Magnus
Hjelmstrom, Peter
Noren, G. Niklas
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 307 - 307
[24] Invasive Pneumococcal Diseases in Korean Adults After the Introduction of Pneumococcal Vaccine into the National Immunization Program
Lee, Mi Suk
INFECTION AND CHEMOTHERAPY, 2023, 55 (04): : 411 - 421
[25] EVALUATING THE EPIDEMIOLOGICAL IMPACT OF INTRODUCTION OF PNEUMOCOCCAL CONJUGATE VACCINE AS PART OF THE NATIONAL IMMUNIZATION SCHEDULE OF KAZAKHSTAN
Balabayev, T.
Kostyuk, A.
Almadiyeva, A.
Sultanov, M.
Absattarova, K.
Almatova, V
VALUE IN HEALTH, 2019, 22 : S355 - S355
[26] Cost-effectiveness analysis of the introduction of the pneumococcal conjugate vaccine (PCV-13) in the Egyptian national immunization program, 2013
Sibak, Mohammed
Moussa, Ibrahim
El-Tantawy, Nasr
Badr, Shaza
Chaudhri, Irtaza
Allam, Essam
Baxter, Louise
Freikha, Saiyed Abo
Hoestlandt, Celine
Lara, Carlos
Hajjeh, Rana
Munier, Aline
VACCINE, 2015, 33 : A182 - A191
[27] Health Disparities in Human Papillomavirus Vaccine Coverage: Trends Analysis From the National Immunization Survey-Teen, 2008-2011
Bednarczyk, Robert A.
Curran, Eileen A.
Orenstein, Walter A.
Omer, Saad B.
CLINICAL INFECTIOUS DISEASES, 2014, 58 (02) : 238 - 241
[28] Capacity of National Malaria Control Programmes to implement vector surveillance: a global analysis
Russell, Tanya L.
Farlow, Robert
Min, Myo
Espino, Effie
Mnzava, Abraham
Burkot, Thomas R.
MALARIA JOURNAL, 2020, 19 (01)
[29] Capacity of National Malaria Control Programmes to implement vector surveillance: a global analysis
Tanya L. Russell
Robert Farlow
Myo Min
Effie Espino
Abraham Mnzava
Thomas R. Burkot
Malaria Journal, 19
[30] The Need for Rotavirus Vaccine Introduction in the National Immunization Program of More Than 100 Countries around the World
Karami, Manoochehr
Berangi, Zeinab
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2018, 39 (01): : 124 - 125

← 1 2 3 4 5 →